TP53 gene deletion in esophageal cancer tissues of patients and its clinical significance

By              

Molecular Medicine Reports, Vol. 7, Iss. 1, 2013-01 ,pp. : 122-126

Spandidos Publications

Access to resources Recommend Favorite

A mutant TP53 gene status is associated with a poor prognosis and anthracycline-resistance in breast cancer patients

By Rahko E.   Blanco G.   Soini Y.   Bloigu R.   Jukkola A.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 447-453

Elsevier

Access to resources Recommend Favorite

Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients

By Powell B.L.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 1, 2001-09 ,pp. : 65-68

Springer Publishing Company

Access to resources Recommend Favorite

Differential Gene Expression of BRCA1, ERBB2 and TP53 Biomarkers between Human Breast Tissue and Peripheral Blood Samples of Breast Cancer Patients

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 4, 2016-02 ,pp. : 519-525

Bentham Science Publishers

Access to resources Recommend Favorite

Prevalence of germline TP53 mutations in HER2+ breast cancer patients

By Rath Michelle  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 193-198

Springer Publishing Company

Access to resources Recommend Favorite